in

Dova Pharmaceuticals CFO Doug Blankenship Resigned

Dova Pharmaceuticals Announces the Appointment of Mark W. Hahn as Chief Financial Officer | Markets Insider

DURHAM, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) — Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the appointment of Mark W. Hahn as the company’s Chief Financial Officer. A veteran Chief Financial Officer of the biotech industry, Mr. Hahn previously served as the Chief Financial officer of Cempra, Inc.


Name: Doug Blankenship

Continent: North America

Country: USA

Company: Dova Pharmaceuticals

Branch: Pharma

Position: CFO

Reason: Resigned

Announcement Date: January 29, 2018, 11:00pm

Resignation Date: January 29, 2018, 11:00pm

Source 1: http://markets.businessinsider.com/news/stocks/Dova-Pharmaceuticals-Announces-the-Appointment-of-Mark-W-Hahn-as-Chief-Financial-Officer-1014549104


Add your submission

Image Video Audio Text Embed

This field is required

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

Report

What do you think?

Leave a Reply